Trend Watch



Sunday, December 14, 2008

Tocomin®SupraBio™ Improves Arterial Compliance

Carotech is pleased to announce data from a human study recently published in Archives of
Pharmacal Research (Sept 2008:31(9), 1212-7) which demonstrated Tocomin®SupraBio™ (a self emulsifying palm tocotrienol complex) was able to reduce arterial stiffness in healthy adults after 2 months oral supplementation.

In this blinded endpoint clinical trial conducted by researchers in The University of Science, Malaysia (USM), 36 healthy volunteers were randomized to receive either the placebo, 50mg, 100mg or 200mg self emulsifying tocotrienol rich vitamin E (Tocovid™SupraBio™, supplied by Hovid Bhd.) daily for 2 months. Measures of arterial compliance (carotid femoral Pulse Wave Velocity and Augmentation Index) and other parameters such as blood pressure and serum lipid profiles were taken before and after treatment. Plasma tocotrienols concentration was also measured.

The results showed that treatment with self emulsifying tocotrienol rich vitamin E produced
significantly higher plasma concentrations of tocotrienols compared to placebo. After 2 months of
supplementation, statistically significant improvement in Augmentation Index (up to 8.7% reduction from baseline) was observed in all the tocotrienols supplemented groups. Significant improvement in Pulse Wave Velocity (up to 10% reduction from baseline) was also seen in subjects who received 100mg and 200mg self emulsifying tocotrienols rich vitamin E. However, treatment has no effect on blood pressure, serum total cholesterol and LDL-cholesterol.

Decreased arterial compliance or increased arterial stiffness is a predictor of cardiovascular events even in healthy individuals. A reduction in both Augmentation Index and Pulse Wave Velocity, as showed by supplementation with self emulsifying palm tocotrienols complex, indicates better arterial compliance, thus reducing the risks of cardiovascular diseases.

“This study showed that tocotrienols reduced arterial stiffness, in addition to other previously
reported cardiovascular benefits including cholesterol lowering and antiplatelet effects.” says WH Leong, Vice President of Carotech Inc.

“SupraBio™, the patented self-emulsifying formulation enhances oral absorption of tocotrienols
independent of food intake.” adds WH Leong.

1 comment:

Anonymous said...

A whole array of anti-obesity pills and medicines are available in the market that helps you to trigger off successful weight loss but the weight loss diet pill Xenical is somewhat different as it prevents around 30% of the fat you take from being absorbed in your system. This further leads to less fat accumulation and ultimately weight loss becomes a reality. For more details on Xenical, visit the website